Editorial: Advances in the Systemic Therapy and Combined Modality Approaches for Head and Neck Cancer

by Argiris, Athanassios, Licitra, Lisa
Published in Front Oncol (2019)

Comment on ‘Impact of intra-arterial chemotherapy including internal carotid artery for advanced paranasal sinus cancers involving the skull base'

by Bossi, Paolo, Orlandi, Ester, Licitra, Lisa
Published in Br J Cancer (2015)

Comment on ‘Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer’

by Bossi, Paolo, Granata, Roberta, Orlandi, Ester, Licitra, Lisa
Published in Br J Cancer (2018)

Response of the Istituto Nazionale Tumori of Milan Head & Neck Cancer Unit to the COVID-19 outbreak

by Resteghini, Carlo, Maggioni, Paola, Di Martino, Vito, Licitra, Lisa
Published in Cancers Head Neck (2020)

Treatment of HER2+ metastatic salivary ductal carcinoma in a pregnant woman: a case report

by Bergamini, Cristiana, Cavalieri, Stefano, Sanguineti, Giuseppe, Farneti, Alessia, Licitra, Lisa
Published in Oxf Med Case Reports (2019)

Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma

by Bossi, Paolo, Resteghini, Carlo, Paielli, Nicholas, Licitra, Lisa, Pilotti, Silvana, Perrone, Federica
Published in Oncotarget (2016)

Head and Neck Cancer

by Psyrri, Amanda, Burtness, Barbara, Harari, Paul M., Vermorken, Jan Baptist, Licitra, Lisa, Sasaki, Clarence T.
Published 2009

The Evolving Role of Taxanes in Combination With Cetuximab for the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Evidence, Advantages, and...

by Guigay, Joël, Tahara, Makoto, Licitra, Lisa, Keilholz, Ulrich, Friesland, Signe, Witzler, Pauline, Mesía, Ricard
Published in Front Oncol (2019)

Transcriptomics and Epigenomics in head and neck cancer: available repositories and molecular signatures

by Serafini, Mara S., Lopez-Perez, Laura, Fico, Giuseppe, Licitra, Lisa, De Cecco, Loris, Resteghini, Carlo
Published in Cancers Head Neck (2020)

Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell ca...

by Machiels, Jean-Pascal H, Licitra, Lisa F, Haddad, Robert I, Tahara, Makoto, Cohen, Ezra EW
Published 2014

Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

by Argiris, Athanassios, Harrington, Kevin J., Tahara, Makoto, Schulten, Jeltje, Chomette, Pauline, Ferreira Castro, Ana, Licitra, Lisa
Published in Front Oncol (2017)

Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Unsuitable to Receive Cisplatin-Based Therapy

by Porceddu, Sandro V., Scotté, Florian, Aapro, Matti, Salmio, Satu, Castro, Ana, Launay-Vacher, Vincent, Licitra, Lisa
Published in Front Oncol (2020)

Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, November 30th 2016

by Ascierto, Paolo A., Daniele, Bruno, Hammers, Hans, Hirsh, Vera, Kim, Joseph, Licitra, Lisa, Nanda, Rita, Pignata, Sandro
Published in J Transl Med (2017)

Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data

by De Cecco, Loris, Nicolau, Monica, Giannoccaro, Marco, Daidone, Maria Grazia, Bossi, Paolo, Locati, Laura, Licitra, Lisa, Canevari, Silvana
Published in Oncotarget (2015)

Bone fracture as a novel immune‐related adverse event with immune checkpoint inhibitors: Case series and large‐scale pharmacovigilance analysis

by Filippini, Daria Maria, Gatti, Milo, Di Martino, Vito, Cavalieri, Stefano, Fusaroli, Michele, Ardizzoni, Andrea, Raschi, Emanuel, Licitra, Lisa
Published in Int J Cancer (2021)

Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell Cancer

by De Cecco, Loris, Giannoccaro, Marco, Marchesi, Edoardo, Bossi, Paolo, Favales, Federica, Locati, Laura D., Licitra, Lisa, Pilotti, Silvana, Canevari, Silvana
Published in Genes (Basel) (2017)

Phase III, randomized, open-label study of durvalumab (MEDI4736) monotherapy, or durvalumab + tremelimumab, versus standard of care (SoC), in recurrent or metastatic (R/M) squamous...

by Ferris, Robert L, Even, Caroline, Haddad, Robert, Tahara, Makoto, Goswami, Trishna, Franks, April, Emeribe, Ugochi, Jarkowski, Anthony, Melillo, Giovanni, Licitra, Lisa
Published in J Immunother Cancer (2015)

Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma

by Pricl, Sabrina, Cortelazzi, Barbara, Dal Col, Valentina, Marson, Domenico, Laurini, Erik, Fermeglia, Maurizio, Licitra, Lisa, Pilotti, Silvana, Bossi, Paolo, Perrone, Federica
Published in Mol Oncol (2014)

Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non‐Nasopharyngeal Head and Neck Cancer: A Systematic Review and Me...

by Szturz, Petr, Wouters, Kristien, Kiyota, Naomi, Tahara, Makoto, Prabhash, Kumar, Noronha, Vanita, Castro, Ana, Licitra, Lisa, Adelstein, David, Vermorken, Jan B.
Published in Oncologist (2017)

Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment

by Galbiati, Donata, Cavalieri, Stefano, Alfieri, Salvatore, Resteghini, Carlo, Bergamini, Cristiana, Orlandi, Ester, Platini, Francesca, Locati, Laura, Giacomelli, Luca, Licitra, Lisa, Bossi, Paolo
Published in Drugs Context (2019)